{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:34:57Z","timestamp":1793205297326,"version":"4.5.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2019,9,5]]},"DOI":"10.18632\/aging.102227","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T04:44:41Z","timestamp":1567658681000},"page":"6941-6950","source":"Crossref","is-referenced-by-count":12,"title":["Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study"],"prefix":"10.18632","volume":"11","author":[{"given":"Peir-Haur","family":"Hung","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ditmanson Medical Foundation Chia-yi Christian Hospital, Chia-yi, Taiwan"},{"name":"Department of Applied Life Science and Health, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ching","family":"Yeh","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan"},{"name":"Department of Public Health, China Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fung-Chang","family":"Sung","sequence":"additional","affiliation":[{"name":"Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan"},{"name":"Graduate Institute of Clinical Medical Science, School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yen","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ditmanson Medical Foundation Chia-yi Christian Hospital, Chia-yi, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsin","family":"Muo","sequence":"additional","affiliation":[{"name":"Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yu","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuen-Jer","family":"Tsai","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Center of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ki.2014.179","article-title":"ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target.","volume":"8","author":"Tarng","year":"2014","journal-title":"Kidney Int"},{"key":"2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jfma.2013.09.004","article-title":"Erythropoiesis-stimulating agents in chronic kidney disease: what have we learned in 25 years?","volume":"11","author":"Tarng","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/ki.1990.229","article-title":"Improvement of brain function in hemodialysis patients treated with erythropoietin.","volume":"3","author":"Schneider","year":"1990","journal-title":"Kidney Int"},{"key":"4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ki.1991.20","article-title":"rHuEPO treatment improves brain and cognitive function of anemic dialysis patients.","volume":"3","author":"Nissenson","year":"1991","journal-title":"Kidney Int"},{"key":"5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S0272-6386(99)70150-2","article-title":"Normalizing hematocrit in dialysis patients improves brain function.","volume":"3","author":"Nissenson","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.mp.4001907","article-title":"Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin.","volume":"1","author":"Wagner","year":"2007","journal-title":"Mol Psychiatry"},{"key":"7","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.","volume":"9","author":"Cerami","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"8","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1007\/s12035-015-9438-1","article-title":"Erythropoietin attenuates the memory deficits in aging rats by rescuing the oxidative stress and inflammation and promoting BDNF releasing.","volume":"5","author":"Yang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"9","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1007\/s12035-017-0568-5","article-title":"Erythropoietin Rescues Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via the EPO-R\/JAK2\/STAT5\/PI3K\/ Akt\/GSK-3\u03b2 Pathway.","volume":"5","author":"Xu","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.17219\/acem\/61044","article-title":"Neuroprotective effects of erythropoietin on Alzheimer\u2019s dementia model in rats.","volume":"2","author":"Erbas","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-160500","article-title":"An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer\u2019s Disease.","volume":"5","author":"Maurice","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/156720205774962683","article-title":"Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity.","volume":"2","author":"Maiese","year":"2005","journal-title":"Curr Neurovasc Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/ndt\/gfp058","article-title":"Efficacy of recombinant erythropoietins: is there unity of international units?","volume":"2","author":"Jelkmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00228-012-1412-5","article-title":"A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia.","volume":"6","author":"Brunkhorst","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"15","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. Defined daily dose: definition and general considerations. http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/ (accessed 2017 May 30)."},{"key":"16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ki.2011.179","article-title":"Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease.","volume":"8","author":"Bamgbola","year":"2011","journal-title":"Kidney Int"},{"key":"17","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.ajkd.2006.03.010","article-title":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.","volume":"4","author":"KDOQI, and National Kidney Foundation","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"18","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1093\/ndt\/gft021","article-title":"Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.","volume":"2","author":"Cozzolino","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"19","doi-asserted-by":"publisher","first-page":"e11016","DOI":"10.1371\/journal.pone.0011016","article-title":"Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat.","volume":"5","author":"Zhang","year":"2010","journal-title":"PLoS One"},{"key":"20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0006-2952(99)00277-4","article-title":"Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical.","volume":"5","author":"Datta","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1046\/j.1460-9568.2002.02125.x","article-title":"Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro.","volume":"1","author":"Navarra","year":"2002","journal-title":"Eur J Neurosci"},{"key":"22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0168-0102(02)00161-X","article-title":"Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation.","volume":"4","author":"Asou","year":"2002","journal-title":"Neurosci Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00213-010-1842-7","article-title":"Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.","volume":"21","author":"Harmer","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"24","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients.","volume":"1","author":"Warnock","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"25","doi-asserted-by":"publisher","first-page":"e009206","DOI":"10.1161\/JAHA.118.009206","article-title":"Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: the AIM - HD Study.","volume":"7","author":"Hung","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000168837","article-title":"Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients.","volume":"1","author":"Huang","year":"1995","journal-title":"Am J Nephrol"},{"key":"27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000169091","article-title":"Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.","volume":"1","author":"Chen","year":"1997","journal-title":"Am J Nephrol"},{"key":"28","first-page":"99","article-title":"Hyporesponsiveness to erythropoietin.","volume":"1","author":"Huang","year":"1997","journal-title":"Perit Dial Int"},{"key":"29","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1038\/sj.ki.4490858","article-title":"Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.","volume":"6","author":"Yang","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1377\/hlthaff.22.3.77","article-title":"Does universal health insurance make health care unaffordable? Lessons from Taiwan.","volume":"2","author":"Hsiao","year":"2003","journal-title":"Health Aff (Millwood)"},{"key":"31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0168-8510(96)00877-9","article-title":"Taiwan\u2019s 1995 health care reform.","volume":"3","author":"Chiang","year":"1997","journal-title":"Health Policy"},{"key":"32","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/ndt\/gfr464","article-title":"Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan.","volume":"2","author":"Fang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"33","doi-asserted-by":"publisher","first-page":"107348","DOI":"10.18632\/oncotarget.22458","article-title":"End stage renal disease is associated with development of dementia.","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eurpsy.2018.05.005","article-title":"Increased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan.","volume":"5","author":"Chi","year":"2018","journal-title":"Eur Psychiatry"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:15:24Z","timestamp":1599074124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,9,15]]}},"alternative-id":["102227","31484803"],"URL":"https:\/\/doi.org\/10.18632\/aging.102227","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]}}}